nach oben

Erschienen in:

26.11.2021 | COVID-19 | Original Article Zur Zeit gratis

Patient-reported outcomes and complications during head and neck cancer radiotherapy before versus during the COVID-19 pandemic

verfasst von: Sarah Nicole Hamilton, Nicole Chau, Eric Berthelet, Jonn Wu, Eric Tran, Melanie Chevrier, Victoria Lau, Matthew Chan, Kimberly DeVries, Vincent LaPointe, Robert A. Olson

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study compares patient-reported outcomes and treatment-related complications during radiotherapy before (August 2019–January 2020) versus during (March–Sept 2020) the COVID-19 pandemic.

Materials and methods

The MD Anderson Symptom Inventory-head and neck module was used to assess curative intent in H&N cancer patients’ symptoms during radiotherapy.

Results

There were 158 patients in the pre-pandemic cohort and 137 patients in the pandemic cohort. There was no significant difference in enteral feeding requirements between the cohorts (21% versus 30%, p = 0.07). Weight loss was higher during the pandemic (mean − 5.6% versus 6.8%, p = 0.03). On multivariate analysis, treatment during the pandemic was associated with higher symptom scores for coughing/choking while eating (2.7 versus 2.1, p = 0.013).

Conclusions

Complication rates during H&N radiotherapy during the COVID-19 pandemic were similar at our institution relative to the pre-pandemic era, although weight loss was greater and patients reported more severe choking/coughing while eating.

Niska JR, Halyard MY, Tan AD, Atherton PJ, Patel SH, Sloan JA (2017) Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer. Qual Life Res 26(7):1721–1731. https://doi.org/10.1007/s11136-017-1528-2CrossRefPubMedPubMedCentral

Falchook AD et al (2016) Comparison of patient- and practitioner-reported toxic effects associated with chemoradiotherapy for head and neck cancer. JAMA Otolaryngol - Head Neck Surg 142(6):517–523. https://doi.org/10.1001/jamaoto.2016.0656CrossRefPubMedPubMedCentral

Pusic A et al (2007) A systematic review of patient-reported outcome measures in head and neck cancer surgery. Otolaryngol - Head Neck Surg 136(4):525–535. https://doi.org/10.1016/j.otohns.2006.12.006CrossRefPubMed

Wilkie JR et al (2019) Big data analysis of associations between patient reported outcomes, observer reported toxicities, and overall quality of life in head and neck cancer patients treated with radiation therapy. Radiother Oncol 137:167–174. https://doi.org/10.1016/j.radonc.2019.04.030CrossRefPubMed

Ringash J (2015) Survivorship and quality of life in head and neck cancer. J Clin Oncol 33(29):3322–3327. https://doi.org/10.1200/JCO.2015.61.4115 (American Society of Clinical Oncology)CrossRefPubMed

Tevetoğlu F, Kara S, Aliyeva C, Yıldırım R, Yener HM (2021) Delayed presentation of head and neck cancer patients during COVID-19 pandemic. Eur Arch Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-021-06728-2CrossRef

Brody RM et al (2020) Changes in head and neck oncologic practice during the COVID-19 pandemic. Head Neck 42(7):1448–1453. https://doi.org/10.1002/hed.26233CrossRefPubMed

Olson RA et al (2018) Provincial development of a patient-reported outcome initiative to guide patient care, quality improvement, and research. Healthc Manag Forum 31(1). https://doi.org/10.1177/0840470417715478.

Holländer-Mieritz C, Johansen J, Johansen C, Vogelius IR, Kristensen CA, Pappot H (2019) Comparing the patients’ subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires. Acta Oncol (Madr) 58(5):603–609. https://doi.org/10.1080/0284186X.2018.1563713CrossRef

10.

Rosenthal DI et al (2014) Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer 120(13):1975–1984. https://doi.org/10.1002/cncr.28672CrossRefPubMed

11.

Cleeland CS (2016) The M. D. Anderson Symptom Inventory User Guide ▪ Version 1

12.

Thomson DJ et al (2020) Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement. Int J Radiat Oncol Biol Phys 107(4):618–627. https://doi.org/10.1016/j.ijrobp.2020.04.016CrossRefPubMedPubMedCentral

13.

Sharma A, Crosby DL (2020) Special considerations for elderly patients with head and neck cancer during the COVID-19 pandemic. Head Neck 42(6):1147–1149. https://doi.org/10.1002/hed.26216CrossRefPubMedPubMedCentral

14.

Prasad A, Brewster R, Newman JG, Rajasekaran K (2020) Optimizing your telemedicine visit during the COVID-19 pandemic: practice guidelines for patients with head and neck cancer. Head Neck 42(6):1317–1321. https://doi.org/10.1002/hed.26197CrossRefPubMedPubMedCentral

15.

Langius JAE et al (2013) More than 10% weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life. Nutr Cancer 65(1):76–83. https://doi.org/10.1080/01635581.2013.741749CrossRefPubMed

16.

Hanna et al GJ (2021) Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19. Oral Oncol. 112. https://doi.org/10.1016/j.oraloncology.2020.105087

17.

Ku PKM et al (2020) Management of dysphagia in the patient with head and neck cancer during COVID-19 pandemic: practical strategy. Head Neck 42(7):1491–1496. https://doi.org/10.1002/hed.26224CrossRefPubMed

18.

Nilsen ML et al (2020) Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic. Head Neck 42(7):1668–1673. https://doi.org/10.1002/hed.26256CrossRefPubMed

19.

Gallo O et al (2021) The impact of the COVID-19 pandemic on the quality of life of head and neck cancer survivors. Support Care Cancer. https://doi.org/10.1007/s00520-021-06198-6CrossRefPubMedPubMedCentral

20.

de Joode K et al (2020) Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective. Eur J Cancer 136:132–139. https://doi.org/10.1016/j.ejca.2020.06.019CrossRefPubMedPubMedCentral

21.

Shaw R et al (2021) Head and neck cancer surgery during the COVID-19 pandemic: an international, multicenter, observational cohort study. Cancer 127(14):2476–2488. https://doi.org/10.1002/cncr.33320CrossRef

22.

Rygalski CJ et al (2021) Time to surgery and survival in head and neck cancer. Ann Surg Oncol 28(2):877–885. https://doi.org/10.1245/s10434-020-09326-4CrossRefPubMed

23.

Chaves ALF et al (2020) Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic. Oral Oncology 107. Elsevier Ltd. https://doi.org/10.1016/j.oraloncology.2020.104734.

Titel: Patient-reported outcomes and complications during head and neck cancer radiotherapy before versus during the COVID-19 pandemic
verfasst von: Sarah Nicole Hamilton
Nicole Chau
Eric Berthelet
Jonn Wu
Eric Tran
Melanie Chevrier
Victoria Lau
Matthew Chan
Kimberly DeVries
Vincent LaPointe
Robert A. Olson
Publikationsdatum: 26.11.2021
Verlag: Springer Berlin Heidelberg
Schlagwort: COVID-19
Erschienen in: Supportive Care in Cancer / Ausgabe 3/2022
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-021-06703-x

Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma

Original Article

Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomes

Open Access
Original Article

Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise?

Zur Zeit gratis
COVID-19
Commentary

Quality of life in patients with non-metastatic breast cancer: evolution during follow-up and vulnerability factors

Original Article

A real-world accuracy of oral mucositis grading in patients undergoing hematopoietic stem cell transplantation

Original Article

Comparative study of royal jelly, propolis, and photobiomodulation therapies in 5-fluorouracil-related oral mucositis in rats

Original Article

Neu im Fachgebiet Onkologie

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

15.01.2025
Urothelkarzinom
Nachrichten

Sind Menschen mit muskelinvasivem Urothelkarzinom für die neoadjuvante platinbasierte Therapie nicht geeignet oder sprechen sie darauf nicht gut an, ist Pembrolizumab eine adjuvante Alternative: Die krankheitsfreie Lebenszeit wird dadurch mehr als verdoppelt.

Duale Checkpointhemmung gegen Melanome verlängert langfristig das Leben

15.01.2025
Melanom
Nachrichten

Im Vergleich zu den Überlebenschancen vor der Einführung von Immuncheckpointhemmern (ICI) ist der Fortschritt durch eine ICI-Kombination mit unterschiedlichen Tagets bei fortgeschrittenem Melanom erstaunlich. Das belegen die finalen Ergebnisse der CheckMate-067-Studie und geben Betroffenen "Hoffnung auf Heilung".

Knochenmarktransplantat als Chance für ältere AML-Patienten

15.01.2025
Akute myeloische Leukämie
Nachrichten

Lange Zeit ist die Transplantation von hämatopoetischen Stammzellen nur bei jüngeren Patienten mit akuter myeloischer Leukämie praktiziert worden. Inzwischen profitieren auch Ältere davon. Ergebnisse einer Studie unterstützen dieses Vorgehen.

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

14.01.2025
Nierenkarzinom
Nachrichten

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Patient-reported outcomes and complications during head and neck cancer radiotherapy before versus during the COVID-19 pandemic